Bavarian Nordic

Adverum Biotechnologies, Inc., based in Redwood City, CA, is dedicated to redefining the standard of care for debilitating ocular diseases through gene therapy. The company's lead program focuses on wet age-related macular degeneration, aiming to develop functional cures that restore vision and prevent blindness by offering a long-lasting, single-administration treatment option. Utilizing a proprietary next-generation adeno-associated virus vector platform, Adverum's investigational therapy Ixo-vec converts retinal cells into continuous therapeutic protein biofactories. This innovative approach aims to alleviate the burden of frequent eye injections while improving accessibility to effective treatments for patients suffering from sight-threatening conditions. Generated from the website

Integrated DNA Technologies Inc. (IDT) is a leading provider of next-generation sequencing solutions, now offering a comprehensive portfolio that includes the xGen NGS products. The company has integrated Archer's innovative assays into its offerings, enhancing capabilities for solid tumor, blood cancer, immune profiling, and genetic disease research. With a focus on advancing CRISPR therapeutics, IDT also provides a new cGMP gRNA manufacturing service to accelerate research projects. The company operates multiple facilities across the United States and internationally, ensuring a robust support network for its customers. Generated from the website

RA Biosources Inc. is a biotechnology company based in San Carlos, California, specializing in the development of monoclonal antibodies for various applications. Led by Dr. Guo, who brings over 25 years of experience in the immunology field, the company is dedicated to providing reliable and high-quality products to its customers. The company has a diverse product catalog that continues to expand, with recent additions including antibodies for Human Interleukin-6 and Cystatin C. RA Biosources is committed to maintaining updated offerings and adapting to the evolving needs of the scientific community. Generated from the website